Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease-Reference-Cited by-同舟云学术

Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease

Published:2023-09 Issue:9 Volume:98 Page:1280-1296
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Lin Zhongqiu,Chen Yanmei,Xiao Zhiwen,Xu Wenlong,Chen Guojun,Huang Chixiong,Feng Weijing,Xie Zhiquan,Liao Wangjun,Liao Yulin,Bin Jianping^ORCID,Feng Li,Wang Shifei^ORCID

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease, 1: Evidence from genetic, epidemiologic, and clinical studies; a consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

2. Chou R, Dana T, Blazina I, Daeges M, Jeanne TL. Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force [published correction appears in JAMA. 2020;323(7):669]. JAMA. 2016;316(19):2008-2024.

3. Primary prevention with statins in the elderly;Mortensen;J Am Coll Cardiol,2018

4. Mild cognitive impairment in geriatrics;Tangalos;Clin Geriatr Med,2018

5. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis;van Asch;Lancet Neurol,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases;British Journal of Pharmacology;2024-03-25

2. Safeguarding Against Stroke Risk by Statins;Mayo Clinic Proceedings;2023-09